Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

(2022) Patrick M. Forde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term outcomes of a phase II trial of neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma of the head and neck (CSCC-HN).

(2022) Neil D. Gross et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

(2021) Alexander M. Menzies et al.   NATURE MEDICINE

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

(2021) Renata Ferrarotto et al.   CLINICAL CANCER RESEARCH

A single centre’s experience of 23 cases of total rhinectomy for the treatment of squamous cell carcinoma involving the nasal vestibule

(2021) Emilien Chabrillac et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Immunotherapy for Non-melanoma Skin Cancer

(2021) Sophia Z. Shalhout et al.   Current Oncology Reports

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

(2021) Danny Rischin et al.   Journal for ImmunoTherapy of Cancer

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

(2020) Michael R Migden et al.   LANCET ONCOLOGY

Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)

(2020) Jean-Jacques Grob et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches

(2020) Dipesh Uprety et al.   Journal of Thoracic Oncology

Epithetic nasal reconstruction after total rhinectomy: oncologic outcomes, immediate and long-term adverse effects and quality of life

(2020) Stefan Mattheis et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

First Bite Syndrome After Parotidectomy: A Case Series and Review of Literature

(2020) Vivian Xu et al.   ENT-EAR NOSE & THROAT JOURNAL

Prospective Evaluation of Health-Related Quality of Life in Patients Undergoing Anterolateral Craniofacial Resection with Orbital Exenteration

(2019) Nobuaki Mukoyama et al.   Journal of Neurological Surgery Part B-Skull Base

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

(2018) T R Cottrell et al.   ANNALS OF ONCOLOGY

Cutaneous squamous cell carcinoma

(2018) Syril Keena T. Que et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

(2018) Michael R. Migden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Update on Keratinocyte Carcinomas

(2018) Kishwer S. Nehal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

(2017) Zachary R. Chalmers et al.   Genome Medicine

Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival

(2016) R C Gerring et al.   EYE

Head and Neck Cutaneous Squamous Cell Carcinoma Requiring Parotidectomy

(2014) Larissa Sweeny et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER